
Celeste A. Roney
Examiner (ID: 19047, Phone: (571)272-5192 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 873 |
| Issued Applications | 472 |
| Pending Applications | 148 |
| Abandoned Applications | 293 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20621675
[patent_doc_number] => 12589169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => Compound and MRI contrast agent containing same
[patent_app_type] => utility
[patent_app_number] => 18/023360
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 1130
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023360
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023360 | Compound and MRI contrast agent containing same | Oct 4, 2021 | Issued |
Array
(
[id] => 17355239
[patent_doc_number] => 20220016035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Extended Release Highly Loaded Drug Compositions
[patent_app_type] => utility
[patent_app_number] => 17/489137
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/489137 | Extended Release Highly Loaded Drug Compositions | Sep 28, 2021 | Pending |
Array
(
[id] => 19716208
[patent_doc_number] => 12201724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Lecithin vesicles for oral delivery
[patent_app_type] => utility
[patent_app_number] => 17/483129
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 22
[patent_no_of_words] => 11112
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483129 | Lecithin vesicles for oral delivery | Sep 22, 2021 | Issued |
Array
(
[id] => 19439998
[patent_doc_number] => 12090225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Specially formulated compositions of inhaled nintedanib and nintedanib salts
[patent_app_type] => utility
[patent_app_number] => 17/469594
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58702
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17469594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/469594 | Specially formulated compositions of inhaled nintedanib and nintedanib salts | Sep 7, 2021 | Issued |
Array
(
[id] => 18691058
[patent_doc_number] => 20230321251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT
[patent_app_type] => utility
[patent_app_number] => 18/024459
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024459
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024459 | LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT | Sep 2, 2021 | Pending |
Array
(
[id] => 18581562
[patent_doc_number] => 20230263814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => METHODS FOR TREATING NEWLY DIAGNOSED MYCOBACTERIUM AVIUM COMPLEX LUNG INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/024040
[patent_app_country] => US
[patent_app_date] => 2021-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -97
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024040
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024040 | METHODS FOR TREATING NEWLY DIAGNOSED MYCOBACTERIUM AVIUM COMPLEX LUNG INFECTIONS | Aug 29, 2021 | Abandoned |
Array
(
[id] => 19195334
[patent_doc_number] => 11992553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Inhalable powder formulations of alginate oligomers
[patent_app_type] => utility
[patent_app_number] => 17/445577
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 18424
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445577 | Inhalable powder formulations of alginate oligomers | Aug 19, 2021 | Issued |
Array
(
[id] => 18724353
[patent_doc_number] => 20230338495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => Vaccine Compositions and Antibodies For Lyme Disease
[patent_app_type] => utility
[patent_app_number] => 18/022087
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -82
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022087
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022087 | Vaccine Compositions and Antibodies For Lyme Disease | Aug 18, 2021 | Pending |
Array
(
[id] => 18656260
[patent_doc_number] => 20230302154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/041811
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041811
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041811 | NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF | Aug 18, 2021 | Pending |
Array
(
[id] => 17272832
[patent_doc_number] => 20210379030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => INHIBITORS OF INTRACELLULAR INVASION
[patent_app_type] => utility
[patent_app_number] => 17/402998
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17402998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/402998 | Inhibitors of intracellular invasion | Aug 15, 2021 | Issued |
Array
(
[id] => 20451777
[patent_doc_number] => 12514820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Pharmaceutical composition of intra-articular corticosteroid for pain control
[patent_app_type] => utility
[patent_app_number] => 18/040454
[patent_app_country] => US
[patent_app_date] => 2021-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 1248
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040454
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040454 | Pharmaceutical composition of intra-articular corticosteroid for pain control | Aug 4, 2021 | Issued |
Array
(
[id] => 19354431
[patent_doc_number] => 12054862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Electrospun PNIPAAm/PCL fiber mats for aligned cell sheets
[patent_app_type] => utility
[patent_app_number] => 17/392805
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 31
[patent_no_of_words] => 9689
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392805 | Electrospun PNIPAAm/PCL fiber mats for aligned cell sheets | Aug 2, 2021 | Issued |
Array
(
[id] => 18595623
[patent_doc_number] => 20230270412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => METHODS AND DEVICES FOR PREPARATION OF ULTRASOUND CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/019310
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019310
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019310 | METHODS AND DEVICES FOR PREPARATION OF ULTRASOUND CONTRAST AGENTS | Aug 2, 2021 | Pending |
Array
(
[id] => 18449490
[patent_doc_number] => 20230190766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => AGENT FOR TREATING MYOPIA, PREVENTING MYOPIA AND/OR SUPPRESSING MYOPIA PROGRESSION
[patent_app_type] => utility
[patent_app_number] => 18/019395
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019395
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019395 | AGENT FOR TREATING MYOPIA, PREVENTING MYOPIA AND/OR SUPPRESSING MYOPIA PROGRESSION | Aug 2, 2021 | Pending |
Array
(
[id] => 17241850
[patent_doc_number] => 20210361593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => PHYTONADIONE COMPOSITIONS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/392405
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392405
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392405 | Phytonadione compositions and related methods | Aug 2, 2021 | Issued |
Array
(
[id] => 17227084
[patent_doc_number] => 20210353640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
[patent_app_type] => utility
[patent_app_number] => 17/390476
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/390476 | Dry powder treprostinil for the treatment of pulmonary hypertension | Jul 29, 2021 | Issued |
Array
(
[id] => 17227085
[patent_doc_number] => 20210353641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
[patent_app_type] => utility
[patent_app_number] => 17/390514
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/390514 | Dry powder treprostinil for the treatment of pulmonary hypertension | Jul 29, 2021 | Issued |
Array
(
[id] => 18565791
[patent_doc_number] => 20230256118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => TEST MEAL, TEST MEAL PACKAGING, METHOD AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/006532
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006532
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006532 | TEST MEAL, TEST MEAL PACKAGING, METHOD AND USES THEREOF | Jul 22, 2021 | Pending |
Array
(
[id] => 18647664
[patent_doc_number] => 20230293434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => COMPOSITIONS COMPRISING miR-690 AND METHODS THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/017377
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017377
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017377 | COMPOSITIONS COMPRISING miR-690 AND METHODS THEREFOR | Jul 20, 2021 | Pending |
Array
(
[id] => 18647931
[patent_doc_number] => 20230293711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => DISRUPTION OF CD28-SIALOSIDE LIGAND COMPLEXES TO ENHANCE T CELL ACTIVATION
[patent_app_type] => utility
[patent_app_number] => 18/041715
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041715
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041715 | DISRUPTION OF CD28-SIALOSIDE LIGAND COMPLEXES TO ENHANCE T CELL ACTIVATION | Jul 20, 2021 | Pending |